A cross-sectional study on the characteristics and distribution of acupoint sensitization in patients with myocardial reperfusion injury after cardiac stenting

Not Applicable

Recruiting

• Conditions: myocardial ischemia reperfusion injury

• Registration Number: ITMCTR2024000107
• Lead Sponsor: Shaanxi University of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 July 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

MIRI Group:
(1) Meet the diagnostic criteria of the European Society of Cardiology Guidelines 2023 for non-ST elevation acute coronary syndromes;
(2) PCI and implantation of at least one stent within one week;
(3) Race, gender, age =18 years old, < 85 years old;
(4) Voluntarily participate in the study and sign the informed consent.
Healthy subject group
(1) Healthy body, no cardiovascular system disease, no mental disease;
(2) Race, gender, age =18 years old, < 85 years old;
(3) Voluntarily participate in the study and sign the informed consent.
Note: Only those who meet the above criteria can be included in this study.

Exclusion Criteria

MIRI Group:
(1) In STEMI patients, the ECG showed continuous ST segment elevation (at least two consecutive ST segment elevations from point J: ?V2 to V3 leads =2.5mm, male < 40 years old, or =2mm, male =40 years old, or =1.5mm, female no age; (2) Other leads =1mm, except left ventricular hypertrophy or left bundle branch block; ? Right chest lead V3R ~ V4R, or back lead V7 ~ V9=0.5mm);
(2) Suffering from malignant tumors, severe infectious diseases, inflammatory diseases, autoimmune diseases, blood system diseases, acute cerebral infarction;
(3) Patients with bullosa skin disease, granulomatous skin disease, metabolic skin disease, and connective tissue disease that are difficult to diagnose clinically;
(4) Participate in any other drug study or treatment study using an unapproved drug within the previous 3 months;
(5) Pregnant and lactating women;
(6) suffering from mental illness or accompanied by serious psychological disorders, unable to cooperate;
Note: Patients who meet any 1 of the above criteria will be excluded.
Healthy subjects Group:
(1) Anxiety, depression, cognitive disabilities, allergies;
(2) Pregnant and lactating women;
(3) Participants in other clinical trials.
Note: Patients who meet any 1 of the above criteria will be excluded.

Study & Design

• Study Type: Observational study
• Study Design: Not specified